Post-Transplantation Cyclophosphamide Following Busulfan And Fludarabine Myeloablative Conditioning Prevents Severe Acute And Chronic Graft-Versus-Host Disease And Minimizes Duration Of Immunosuppression: Results Of A Multi-Institutional Trial In Patients With High-Risk Hematologic Malignancies